×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: TFEB Activators for Parkinson's Disease
mechanism
1,450 words
KG: ent-prot-7a94bd2a
2026-03-26
kind:mechanism
section:mechanisms
state:published
Contents
TFEB Activators for Parkinson's Disease
⚙
Mechanism Info
Name
TFEB Activators for Parkinson's Disease
Summary
Mechanism of action for TFEB (transcription factor EB) activators in Parkinson's disease, including lysosomal biogenesis, autophagy enhancement, and protein clearance
Knowledge Graph
Related Hypotheses (8)
Cell-Type Specific TFEB Modulation
Score: 0.48
Temporal TFEB Modulation Therapy
Score: 0.37
The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.40
TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.47
TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.40
Lysosomal Positioning Dynamics Modulation
Score: 0.43
APOE-Dependent Autophagy Restoration
Score: 0.61
Sphingomyelin Synthase Activators for Raft Remodeling
Score: 0.47
Show 3 more
Related Analyses (30)
Does TFEB dysfunction cause neurodegeneration or represent a
neurodegeneration · completed
What determines the specificity of calcium-dependent PPP3/ca
neurodegeneration · failed
How does controlled lysosomal membrane permeabilization indu
neurodegeneration · failed
Why do structurally diverse sugars (trehalose, melibiose, la
neurodegeneration · failed
Does TFEB dysfunction causally drive neurodegeneration or re
molecular biology · failed
Does TFEB activation directly restore mutant GBA enzyme acti
molecular biology · failed
What validated biomarkers can determine optimal TFEB activit
neurodegeneration · failed
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Show 25 more
Related Experiments (30)
Transcriptome sequencing of cardiac fibroblasts in TFEB over
exploratory · proposed · Score: 0.90
Trehalose-induced lysosomal changes and TFEB activation
exploratory · proposed · Score: 0.90
Trehalose-induced lysosomal membrane permeabilization and TF
exploratory · proposed · Score: 0.90
TFEB silencing and misfolded protein degradation
exploratory · proposed · Score: 0.88
Protein expression analysis and cell migration assays in car
exploratory · proposed · Score: 0.88
Functional validation of trehalose effects on misfolded prot
exploratory · proposed · Score: 0.85
ChIP-qPCR validation of TFEB binding to Thbs1 promoter
exploratory · proposed · Score: 0.85
Trehalose analog testing for autophagy induction
exploratory · proposed · Score: 0.82
Gene expression analysis of autophagy targets following treh
exploratory · proposed · Score: 0.85
Trehalose-induced autophagy gene expression analysis
exploratory · proposed · Score: 0.85
PPP3/calcineurin-dependent TFEB dephosphorylation mechanism
exploratory · proposed · Score: 0.80
Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson
clinical · proposed · Score: 0.40
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40
AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40
AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40
Computational Modeling of Alpha-Synuclein Propagation in PD
validation · proposed · Score: 0.40
Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
validation · proposed · Score: 0.40
Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.40
Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.40
Antiviral Therapy Trial for Parkinson's Disease
clinical · proposed · Score: 0.40
Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson'
clinical · proposed · Score: 0.40
Axonal Transport Dysfunction Validation in Parkinson's Disea
clinical · proposed · Score: 0.40
cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Chaperone-Mediated Autophagy Dysfunction in PD - Experiment
clinical · proposed · Score: 0.40
Combination Therapy Sequencing in Parkinson's Disease
validation · proposed · Score: 0.40
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40
Show 25 more